January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Cellistic
Cellistic enables the development of iPSC-based allogeneic cell therapies for immuno-oncology and regenerative medicine by emphasizing scalability, cost-efficiency, and safety—helping therapeutic developers accelerate translation to the clinic.